Pure Global

Human chorionic gonadotropin beta-core fragment IVD, control - UK MHRA Medical Device Registration

Human chorionic gonadotropin beta-core fragment IVD, control is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 128619. The device is manufactured by Biochemical Diagnostics, Inc from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Advena Ltd.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Human chorionic gonadotropin beta-core fragment IVD, control
MHRA Device ID: 128619โ€ขRef: 128619

Device Type

In Vitro Diagnostic Device

Devices

Human chorionic gonadotropin beta-core fragment IVD, control

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Dec 20, 2023

Manufacturer Information

Address

180 Heartland Blvd.

Edgewood, New York, United States

Created Date

Dec 27, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

Pure Offices Plato Close

Warwick, England, United Kingdom

Postcode: CV34 6WE

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing